Revelation Biosciences, Inc. (REVB)
1.01
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 11:22
Revelation Biosciences Market Cap : 3.948M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 3.948M |
| September 04, 2026 | 3.948M |
| September 03, 2026 | 3.948M |
| September 02, 2026 | 3.908M |
| September 01, 2026 | 3.856M |
| August 31, 2026 | 3.908M |
| August 28, 2026 | 4.104M |
| August 27, 2026 | 4.026M |
| August 26, 2026 | 3.732M |
| August 25, 2026 | 3.908M |
| August 24, 2026 | 4.299M |
| August 21, 2026 | 4.260M |
| August 20, 2026 | 4.182M |
| August 19, 2026 | 4.338M |
| August 18, 2026 | 4.338M |
| August 17, 2026 | 4.495M |
| August 14, 2026 | 4.100M |
| August 13, 2026 | 4.338M |
| August 12, 2026 | 4.338M |
| August 11, 2026 | 4.416M |
| August 10, 2026 | 4.416M |
| August 07, 2026 | 4.456M |
| August 06, 2026 | 4.377M |
| August 05, 2026 | 4.495M |
| August 04, 2026 | 4.416M |
| Date | Value |
|---|---|
| August 03, 2026 | 3.987M |
| July 31, 2026 | 3.713M |
| July 30, 2026 | 3.890M |
| July 29, 2026 | 3.77M |
| July 28, 2026 | 4.056M |
| July 27, 2026 | 4.143M |
| July 24, 2026 | 4.143M |
| July 23, 2026 | 4.182M |
| July 22, 2026 | 4.495M |
| July 21, 2026 | 4.495M |
| July 20, 2026 | 4.534M |
| July 17, 2026 | 4.612M |
| July 16, 2026 | 4.416M |
| July 15, 2026 | 4.260M |
| July 14, 2026 | 4.065M |
| July 13, 2026 | 3.857M |
| July 10, 2026 | 3.908M |
| July 09, 2026 | 3.811M |
| July 08, 2026 | 3.784M |
| July 07, 2026 | 3.869M |
| July 06, 2026 | 3.987M |
| July 02, 2026 | 4.221M |
| July 01, 2026 | 4.065M |
| June 30, 2026 | 4.026M |
| June 29, 2026 | 4.065M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Shuttle Pharmaceuticals Holdings, Inc. | 1.943M |
| ACADIA Pharmaceuticals, Inc. | 4.797B |
| Agenus, Inc. | 305.13M |
| Alnylam Pharmaceuticals, Inc. | 34.26B |
| Amgen, Inc. | 212.44B |
Market Cap Related Metrics
| Price to Book Value | 0.3921 |
| Price | 1.01 |
| Earnings Yield | -1.22K% |